Recent Quotes (30 days)

You have no recent quotes
chg | %

Roche Holding Ltd. (ADR)  

(Public, OTCMKTS:RHHBY)   Watch this stock  
Find more results forPINK:RHHBY
34.15
-0.01 (-0.01%)
After Hours: 34.13 -0.03 (-0.08%)
Aug 31, 4:09p.m. GMT-4  
OTCMKTS data delayed by 15 mins - Disclaimer
Currency in USD
Range 33.86 - 34.30
52 week 32.08 - 38.54
Open 34.07
Vol / Avg. 528,905.00/839,455.00
Mkt cap 236,597.54M
P/E 24.31
Div/yield 1.00/2.94
EPS 1.40
Shares 689.74M
Beta 0.67
Inst. own 17%
Nov 25, 2015
Roche Holding AG at Exane BNP Paribas SRI/ESG Conference Add to calendar
Nov 10, 2015
Roche Holding AG at Credit Suisse Healthcare Conference Add to calendar
Nov 10, 2015
Roche Holding AG at UBS European Conference Add to calendar
Nov 5, 2015
Roche Holding AG Roche Pharma Day - 5:30a.m. GMT-5 - Add to calendar
Nov 5, 2015
Roche Holding AG at Citi Global Healthcare Conference Add to calendar
Oct 22, 2015
Q3 2015 Roche Holding AG Corporate Sales Release - 1:00a.m. GMT-4 - Add to calendar
Oct 22, 2015
Q3 2015 Roche Holding AG Corporate Sales Call Add to calendar
Sep 29, 2015
Roche Holding AG at Sanford C Bernstein European Strategic Decisions Conference Add to calendar
Sep 28, 2015
Roche Holding AG Analyst Event at European Cancer Congress 2015 - 11:00a.m. GMT-4 - Add to calendar
Sep 17, 2015
Roche Holding AG at Morgan Stanley Healthcare Conference Add to calendar
  

Key stats and ratios

Q4 (Dec '14) 2014
Net profit margin 15.90% 20.09%
Operating margin 24.25% 28.76%
EBITD margin - 39.96%
Return on average assets 11.29% 13.84%
Return on average equity 40.95% 48.00%
Employees 88,509 -
CDP Score - 99 A-

Address

Grenzacherstr. 124
BASEL, 4058
Switzerland
+41-9-732354295 (Phone)

Website links

External links

Description

Roche Holding AG is a Switzerland-based pharmaceuticals and diagnostics company. It discovers, develops and provides diagnostic and therapeutic products and services from early detection and prevention of diseases to diagnosis, treatment and treatment monitoring. The Company has two divisions: Pharmaceuticals and Diagnostics. It operates worldwide containing the United States, Western Europe, Japan and Asia-Pacific, among others. Diagnostics include five areas: Applied Science, Diabetes Care, Molecular Diagnostics, Tissue Diagnosis and Professional Diagnostics. It operates in five geographical regions: Europe, Middle East and Africa (EMEA); North America; Asia-Pacific; Latin America, and Japan. In September 2014, it accepted for payment of all shares of InterMune Inc. through its wholly owned subsidiary Klee Acquisition Corporation. Additionally, it offers hardware and software solutions for genomic analysis.

Officers and directors

Severin Schwan Chairman of the Corporate Executive Committee, Chief Executive Officer, Director
Age: 48
Alan Hippe Member of the Corporate Executive Committee, Chief Financial Officer, Information Technology Officer
Age: 48
Stephan Feldhaus Member of the Enlarged Corporate Executive Committee, Head Group Communications
Age: 53
Sophie Kornowski-Bonnet Member of the Enlarged Corporate Executive Committee, Head of Roche Partnering
Age: 50
Osamu Nagayama Member of the Enlarged Corporate Executive Committee, President and Chief Executive Officer of Chugai
Age: 67
John C. Reed M.D., Ph.D. Member of the Enlarged Corporate Executive Committee, Head of Roche Pharma Research & Early Development
Age: 57
Michael David Varney Member of the Enlarged Corporate Executive Committee, Head Genetech Research and Early Development
Age: 57
Urs Jaisli Chief Compliance Officer
Age: 59
Gottlieb A. Keller Member of the Group Executive Committee, General Counsel, Secretary to the Board of Directors
Age: 61
Silvia Ayyoubi Member of the Corporate Executive Committee, Head of Group Human Resources
Age: 62